Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Lamellar events related to insulin-like growth factor-1 receptor signalling in two models relevant to endocrinopathic laminitis.

Lane HE, Burns TA, Hegedus OC, Watts MR, Weber PS, Woltman KA, Geor RJ, McCutcheon LJ, Eades SC, Mathes LE, Belknap JK.

Equine Vet J. 2017 Sep;49(5):643-654. doi: 10.1111/evj.12663. Epub 2017 Mar 2.

PMID:
28078757
2.

The need for veterinarians in biomedical research.

Rosol TJ, Moore RM, Saville WJ, Oglesbee MJ, Rush LJ, Mathes LE, Lairmore MD.

J Vet Med Educ. 2009 Spring;36(1):70-5. doi: 10.3138/jvme.36.1.70. Review.

3.

Identification of a novel common proviral integration site, flit-1, in feline leukemia virus induced thymic lymphoma.

Fujino Y, Liao CP, Zhao YS, Pan J, Mathes LE, Hayes KA, Ohno K, Tsujimoto H, Roy-Burman P.

Virology. 2009 Mar 30;386(1):16-22. doi: 10.1016/j.virol.2009.01.021. Epub 2009 Feb 8.

4.

Animal models of retroviral encephalopathies: feline model.

Podell M, Buck WR, Hayes KA, Gavrilin MA, Mathes LE.

Curr Protoc Neurosci. 2002 Feb;Chapter 9:Unit 9.9. doi: 10.1002/0471142301.ns0909s17. Review.

PMID:
18428574
5.

Progress in the discovery and definition of monoclonal antibodies for use in feline research.

Meister RK, Taglinger K, Haverson K, Strohminger N, Mathes LE.

Vet Immunol Immunopathol. 2007 Sep 15;119(1-2):38-46. Epub 2007 Jun 20.

PMID:
17675164
6.

In vivo expression of GFP transgene delivered via a replicating feline leukemia virus.

Pan J, Al-Dubaib M, Liao CP, Fujino Y, Hinton DR, Hayes KA, Mathes LE, Roy-Burman P.

Vet Microbiol. 2005 Oct 31;110(3-4):181-95.

PMID:
16143471
7.
8.

Expression of equine glucose transporter type 4 in skeletal muscle after glycogen-depleting exercise.

Jose-Cunilleras E, Hayes KA, Toribio RE, Mathes LE, Hinchcliff KW.

Am J Vet Res. 2005 Mar;66(3):379-85.

PMID:
15822579
9.
10.

Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDV.

Francke S, Orosz CG, Hsu J, Mathes LE.

Antimicrob Agents Chemother. 2002 Sep;46(9):2865-71.

11.

Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes.

Gavrilin MA, Mathes LE, Podell M.

J Neurovirol. 2002 Jun;8(3):240-9.

PMID:
12053278
12.

SV40 Immortalization of feline fibroblasts as targets for MHC-restricted cytotoxic T-cell assays.

Köksoy S, Phipps AJ, Hayes KA, Mathes LE.

Vet Immunol Immunopathol. 2001 May 30;79(3-4):285-95.

PMID:
11389962
13.

The feline model of neuroAIDS: understanding the progression towards AIDS dementia.

Podell M, March PA, Buck WR, Mathes LE.

J Psychopharmacol. 2000;14(3):205-13. Review.

PMID:
11106298
14.

Inhibition of feline leukemia virus subgroup A infection by coinoculation with subgroup B.

Phipps AJ, Hayes KA, Al-dubaib M, Roy-Burman P, Mathes LE.

Virology. 2000 Nov 10;277(1):40-7.

15.
16.

Effect of zidovudine on the primary cytolytic T-lymphocyte response and T-cell effector function.

Francke S, Orosz CG, Hayes KA, Mathes LE.

Antimicrob Agents Chemother. 2000 Jul;44(7):1900-5.

17.

Differential pathogenicity of two feline leukemia virus subgroup A molecular clones, pFRA and pF6A.

Phipps AJ, Chen H, Hayes KA, Roy-Burman P, Mathes LE.

J Virol. 2000 Jul;74(13):5796-801.

18.

Transfer of the feline erythropoietin gene to cats using a recombinant adeno-associated virus vector.

Beall CJ, Phipps AJ, Mathes LE, Stromberg P, Johnson PR.

Gene Ther. 2000 Mar;7(6):534-9.

19.

Neurophysiologic and immunologic abnormalities associated with feline immunodeficiency virus molecular clone FIV-PPR DNA inoculation.

Phipps AJ, Hayes KA, Buck WR, Podell M, Mathes LE.

J Acquir Immune Defic Syndr. 2000 Jan 1;23(1):8-16.

PMID:
10708051
20.

Frontal lobe neuronal injury correlates to altered function in FIV-infected cats.

Podell M, Maruyama K, Smith M, Hayes KA, Buck WR, Ruehlmann DS, Mathes LE.

J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):10-8.

PMID:
10534142
21.
22.

Pathogenicity induced by feline leukemia virus, Rickard strain, subgroup A plasmid DNA (pFRA).

Chen H, Bechtel MK, Shi Y, Phipps A, Mathes LE, Hayes KA, Roy-Burman P.

J Virol. 1998 Sep;72(9):7048-56.

23.

In vivo evolution and selection of recombinant feline leukemia virus species.

Bechtel MK, Mathes LE, Hayes KA, Phipps AJ, Roy-Burman P.

Virus Res. 1998 Mar;54(1):71-86.

PMID:
9660073
24.

Evidence that high-dosage zidovudine at time of retrovirus exposure reduces antiviral efficacy.

Mathes LE, Hayes KA, Kociba G.

Antimicrob Agents Chemother. 1996 Sep;40(9):2183-6.

25.

Feline leukemia virus variants in experimentally induced thymic lymphosarcomas.

Pandey R, Bechtel MK, Su Y, Ghosh AK, Hayes KA, Mathes LE, Roy-Burman P.

Virology. 1995 Dec 20;214(2):584-92.

26.

Early suppression of viremia by ZDV does not alter the spread of feline immunodeficiency virus infection in cats.

Hayes KA, Wilkinson JG, Frick R, Francke S, Mathes LE.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jun 1;9(2):114-22.

PMID:
7749786
27.

Acute feline leukemia virus infection causes altered energy balance and growth inhibition in weanling cats.

Hartke JR, Hayes KA, Buffington CA, Mathes LE, Rojko JL.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1;9(1):11-9.

PMID:
7712229
28.
29.

Effects of whole blood lysis and fixation on the infectivity of human T-lymphotropic virus type 1 (HTLV-I).

Ericson JG, Trevino AV, Toedter GP, Mathes LE, Newbound GC, Lairmore MD.

Cytometry. 1994 Mar 15;18(1):49-54.

30.

Recombination between feline exogenous and endogenous retroviral sequences generates tropism for cerebral endothelial cells.

Chakrabarti R, Hofman FM, Pandey R, Mathes LE, Roy-Burman P.

Am J Pathol. 1994 Feb;144(2):348-58.

31.

Pathogenicity of a subgroup C feline leukemia virus (FeLV) is augmented when administered in association with certain FeLV recombinants.

Mathes LE, Pandey R, Chakrabarti R, Hofman FM, Hayes KA, Stromberg P, Roy-Burman P.

Virology. 1994 Jan;198(1):185-95.

PMID:
8259654
32.

Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats.

Hayes KA, Lafrado LJ, Erickson JG, Marr JM, Mathes LE.

J Acquir Immune Defic Syndr (1988). 1993 Feb;6(2):127-34.

PMID:
8381867
33.

Loss of neutrophil and natural killer cell function following feline immunodeficiency virus infection.

Hanlon MA, Marr JM, Hayes KA, Mathes LE, Stromberg PC, Ringler S, Krakowka S, Lafrado LJ.

Viral Immunol. 1993 Summer;6(2):119-24.

PMID:
8105792
34.

Pre- and postexposure chemoprophylaxis: evidence that 3'-azido-3'-dideoxythymidine inhibits feline leukemia virus disease by a drug-induced vaccine response.

Mathes LE, Polas PJ, Hayes KA, Swenson CL, Johnson S, Kociba GJ.

Antimicrob Agents Chemother. 1992 Dec;36(12):2715-21.

35.

Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes.

Rigby MA, Rojko JL, Stewart MA, Kociba GJ, Cheney CM, Rezanka LJ, Mathes LE, Hartke JR, Jarrett O, Neil JC.

J Gen Virol. 1992 Nov;73 ( Pt 11):2839-47.

PMID:
1331290
37.

Lymphocytotoxic strains of feline leukemia virus induce apoptosis in feline T4-thymic lymphoma cells.

Rojko JL, Fulton RM, Rezanka LJ, Williams LL, Copelan E, Cheney CM, Reichel GS, Neil JC, Mathes LE, Fisher TG, et al.

Lab Invest. 1992 Apr;66(4):418-26.

PMID:
1349933
38.

Incidence of localized feline leukemia virus infection in cats.

Hayes KA, Rojko JL, Mathes LE.

Am J Vet Res. 1992 Apr;53(4):604-7.

PMID:
1316726
39.

Detection of simian T-lymphotropic virus type I using the polymerase chain reaction.

Dezzutti CS, Lazo A, Yee JY, Blakeslee JR, Mathes LE, Brown BG, Lairmore MD.

Int J Cancer. 1992 Mar 12;50(5):805-10.

PMID:
1312066
40.

The effects of perfluorodecanoic acid (PFDA) on humoral, cellular, and innate immunity in Fischer 344 rats.

Nelson DL, Frazier DE Jr, Ericson JE, Tarr MJ, Mathes LE.

Immunopharmacol Immunotoxicol. 1992;14(4):925-38.

PMID:
1294628
41.

Prophylactic and therapeutic effects of phosphonoformate against feline leukemia virus in vitro.

Swenson CL, Polas PJ, Cheney CM, Kociba GJ, Mathes LE.

Am J Vet Res. 1991 Dec;52(12):2010-5.

PMID:
1724122
42.
43.

Evaluation of antiviral activity and toxicity of dextran sulfate in feline leukemia virus-infected cats.

Mathes LE, Hayes KA, Swenson CL, Polas PJ, Weisbrode SE, Kociba GJ.

Antimicrob Agents Chemother. 1991 Oct;35(10):2147-50.

44.

Age-related differences in phosphonoformate-induced bone toxicity in cats.

Swenson CL, Weisbrode SE, Nagode LA, Hayes KA, Steinmeyer CL, Mathes LE.

Calcif Tissue Int. 1991 May;48(5):353-61.

PMID:
1829019
45.

In vitro replication and cytopathogenicity of the feline immunodeficiency virus for feline T4 thymic lymphoma 3201 cells.

Tochikura TS, Hayes KA, Cheney CM, Tanabe-Tochikura A, Rojko JL, Mathes LE, Olsen RG.

Virology. 1990 Nov;179(1):492-7.

PMID:
1699355
46.

In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model.

Polas PJ, Swenson CL, Sams R, Cheney CM, Hayes KA, Tarr MJ, Kociba GJ, Mathes LE.

Antimicrob Agents Chemother. 1990 Jul;34(7):1414-21.

47.

A feline large granular lymphoma and its derived cell line.

Cheney CM, Rojko JL, Kociba GJ, Wellman ML, Di Bartola SP, Rezanka LJ, Forman L, Mathes LE.

In Vitro Cell Dev Biol. 1990 May;26(5):455-63.

PMID:
2161827
48.

Age-related differences in pharmacokinetics of phosphonoformate in cats.

Swenson CL, Sams RA, Polas PJ, Michael DF, Mathes LE.

Antimicrob Agents Chemother. 1990 May;34(5):871-4.

49.

Prevalence of disease in nonviremic cats previously exposed to feline leukemia virus.

Swenson CL, Kociba GJ, Mathes LE, Hand PJ, Neer CA, Hayes KA, Olsen RG.

J Am Vet Med Assoc. 1990 Apr 1;196(7):1049-52.

PMID:
2158493
50.

Biological effects of staphylococcal protein A immunotherapy in cats with induced feline leukemia virus infection.

Lafrado LJ, Mathes LE, Zack PM, Olsen RG.

Am J Vet Res. 1990 Mar;51(3):482-6.

PMID:
1690524

Supplemental Content

Loading ...
Support Center